Literature DB >> 25709086

Cloning, expression, and characterization of a novel xylose reductase from Rhizopus oryzae.

Min Zhang1, Shao-tong Jiang1, Zhi Zheng1, Xing-jiang Li1, Shui-zhong Luo1, Xue-feng Wu1.   

Abstract

Rhizopus oryzae is valuable as a producer of organic acids via lignocellulose catalysis. R. oryzae metabolizes xylose, which is one component of lignocellulose hydrolysate. In this study, a novel NADPH-dependent xylose reductase gene from R. oryzae AS 3.819 (Roxr) was cloned and expressed in Pichia pastoris GS115. Homology alignment suggested that the 320-residue protein contained domains and active sites belonging to the aldo/keto reductase family. SDS-PAGE demonstrated that the recombinant xylose reductase has a molecular weight of approximately 37 kDa. The optimal catalytic pH and temperature of the purified recombinant protein were 5.8 and 50 °C, respectively. The recombinant protein was stable from pH 4.4 to 6.5 and at temperatures below 42 °C. The recombinant enzyme has bias for D-xylose and L-arabinose as substrates and NADPH as its coenzyme. Real-time quantitative reverse transcription PCR tests suggested that native Roxr expression is regulated by a carbon catabolite repression mechanism. Site-directed mutagenesis at two possible key sites involved in coenzyme binding, Thr(226)  → Glu(226) and Val(274)  → Asn(274), were performed, respectively. The coenzyme specificity constants of the resulted RoXR(T226E) and RoXR(V274N) for NADH increased 18.2-fold and 2.4-fold, which suggested possibility to improve the NADH preference of this enzyme through genetic modification.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Pichia pastoris; Real-time qRT-PCR; Rhizopus oryzae; Site-directed mutagenesis; Xylose reductase

Mesh:

Substances:

Year:  2015        PMID: 25709086     DOI: 10.1002/jobm.201400786

Source DB:  PubMed          Journal:  J Basic Microbiol        ISSN: 0233-111X            Impact factor:   2.281


  1 in total

1.  Rapidly progressive bilateral optic nerve and retinal infarctions due to rhinocerebral mucormycosis and pseudoephedrine use.

Authors:  Alexander E Merkler; Isha Duggal; Ulrike Kaunzner; Carolina B Maciel; Alexandra M Miller; Theresa Scognamiglio; Marc J Dinkin
Journal:  Neurol Clin Pract       Date:  2016-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.